Vaccine reserach

NHSBT antibody study looks at vaccinated and previously infected

NHS Blood and Transplant (NHSBT) is carrying out a vaccination study (C-Velvet)¸ based on two small studies (1) (2).The study will look at whether vaccinations create a huge increase in antibody levels, in people who have already had coronavirus. Researchers believe it will generate antibody levels around 100-200 times higher than in people who have not had the virus.

The study will provide data for research into antibody therapies able to fight multiple viral strains. Previous research showed that exposure to both the virus and the vaccine could lead to a stronger, more broadly effective response against different strains of the virus.

Research will involve going back to 100 people who donated convalescent plasma after recovering from Covid-19. They are now being contacted by NHSBT to give blood samples 28 days after their vaccination. The neutralising antibody levels will be compared against the antibody levels of when they were plasma donors. Around 50 people have given samples so far.

Dr Lise Estcourt, Head of NHSBT’s Clinical Trials Unit, and study lead, said: “They found an increase in the cross reactivity of the antibodies against different viral strains.

“Our C-Velvet study could have two benefits for potential treatments. We may identify plasma ‘super donors’ who provide the very high antibody levels needed for any trial of hyperimmune plasma.

“Secondly, our study could inform the development of monoclonal antibody therapies which react against more viral variants.”

Minister for Innovation Lord Bethell, said: “The UK is home to a thriving industry for life sciences, research and development, and the launch of the C-Velvet study will be an important addition to our immense quota of UK-based Covid-19 studies.

“These potential “super donors” could be invaluable for future Covid-19 treatments and trials to fight the virus and keep people safe.

“I look forward to seeing what this study will bring to bolster our fast-growing knowledge of the virus and its weaknesses so we can all build back better.”

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all